Here are 12 key notes on spine and orthopedic device companies this week.
Amedica released its first quarter financial results and reported 7 percent increase in silicon nitride ceramic revenue.
Zacks restated the "hold" rating for Bacterin stock.
Bacterin revenue was up 6.6 percent to $9.5 million in the first quarter.
Ceterix Orthopaedics entered into a term loan agreement for up to $35 million in funds.
K2M reported total revenue growth in the first quarter — total reported revenue was up 19.3 percent year-over-year, reaching $50.4 million in the first quarter.
Mazor released its first quarter financial report with recurring quarterly revenue increasing significantly year-over-year.
NuVasive increased revenue in the first quarter of 2015 ahead of launching a new sagittal alignment-focused system.
Plano-based Texas Back Institute performed the first surgery using Safe Orthopaedics' products in the United States.
St. Jude Medical purchased Spinal Modulation.
Memorial Hermann-The Woodlands (Texas) Hospital incorporated Stryker's MAKOplasty procedure.
Tornier's first quarter revenue was $88.1 million, a 1 percent decrease over the same period last year.
The Chinese Firm Xi'an Particle Cloud Advanced Materials Technology is working on a three-dimensional printed artificial bone structure using the Filament Free Printing process.
More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics' 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways